CHOLESTYRAMINE LIGHT
CHOLESTYRAMINE LIGHT is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: CHOLESTYRAMINE LIGHT; Generic name: CHOLESTYRAMINE LIGHT; Drug class: Bile Acid Sequestrant [EPC].
| Brand name | CHOLESTYRAMINE LIGHT |
|---|---|
| Generic name | CHOLESTYRAMINE LIGHT |
| Drug class | Bile Acid Sequestrant [EPC] |
| Manufacturer | EPIC PHARMA, LLC |
| Used for | INDICATIONS AND USAGE 1) Cholestyramine for Oral Suspension, USP Light powder is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. Cholestyramine for Oral Suspension, USP Light powder may be useful to lower LDL cholesterol in patients who also have hypertriglyceridemia, but it is not indicated where hypertriglyceridemia is the abnormality of most concern. Therapy with lipid-altering agents should be a component of multiple risk factor intervention in those individuals at significantly increased risk for atherosclerotic |
| Dosage | DOSAGE AND ADMINISTRATION The recommended starting adult dose for Cholestyramine for Oral Suspension, USP Light powder is one pouch or one level scoopful (5.7 grams of Cholestyramine for Oral Suspension, USP Light powder contains 4 grams of anhydrous cholestyramine resin) once or twice a day. The recommended maintenance dose for Cholestyramine for Oral Suspension, USP Light powder is 2 to 4 pouches or scoopfuls daily (8 to 16 grams anhydrous cholestyramine resin) divided into two doses. It is re |
| Warnings | WARNINGS PHENYLKETONURICS: CHOLESTYRAMINE FOR ORAL SUSPENSION, USP LIGHT POWDER CONTAINS 22.4 mg PHENYLALANINE PER 5.7 GRAM DOSE. |
| Active ingredient(s) | CHOLESTYRAMINE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=00990dec-7618-4cc8-9387-48c2cea8df1c |